IPO Advisory · SME IPO
Turn factory capability into a public-market story that can survive diligence, scale scrutiny and promoter transition.
SME IPO advisory for manufacturing companies in India begins well before the prospectus is drafted. Investors need to understand whether capacity additions will earn returns, whether working capital is controlled and whether the business can operate without every decision returning to the promoter. Gladwin works on that leadership and governance layer: a listing-capable CFO and company secretary, an independent board, reliable management information and accountable plant leadership. We work alongside the merchant banker, counsel and auditor; we do not replace them or perform regulated capital-markets work.
IPO route
BSE SME or NSE Emerge
Best for
Profitable promoter-led manufacturers funding capacity or diversification
Typical timeline
Often 9–15 months after records and governance are ready
What we own
Leadership, board and governance readiness
Eligibility snapshot
Eligibility as per current SEBI and exchange norms—confirm the current position and your specific facts with your merchant banker.
Route comparison
| Decision lens | SME IPO | Main Board IPO |
|---|---|---|
| Eligibility | Post-issue paid-up capital at face value up to ₹25 crore, plus exchange criteria | SEBI ICDR eligibility route and exchange listing conditions |
| Investor base | Higher application lots; specialist and growth-oriented investors | Broader retail and institutional participation |
| Issue support | Mandatory market making under the SME framework | No equivalent SME market-maker requirement |
| Compliance load | Public-company obligations calibrated to the SME platform | More extensive disclosure and quarterly market scrutiny |
| Leadership implication | Institutionalise now; preserve a credible migration path | Build full listed-company capacity before filing |
For a mid-market manufacturer, an SME listing can finance a debottlenecking programme, a new machining line, backward integration or a larger working-capital cycle without forcing the company to present itself prematurely as a Main Board issuer. The strongest cases tie each rupee of fresh capital to throughput, margin resilience or customer qualification. A vague promise of ‘general expansion’ is much less persuasive than a board-approved capex case with commissioning dates, utilisation ramps and accountable owners.
The route also changes the company itself. Promoter judgement must become repeatable management process; monthly factory reviews must become disclosure-grade records; and customer or supplier dependence must be discussed openly. We help the leadership team build that institutional spine before due diligence turns every informal practice into an urgent exception.
Manufacturing scrutiny is forensic because the operating story sits across systems. Revenue can rise while cash is trapped in receivables and slow-moving stock; reported capacity can look impressive while bottleneck equipment limits saleable output. Reviewers will connect the prospectus narrative to inventory ageing, yield loss, power usage, customer approvals, contingent liabilities and the actual condition of the asset base.
Related-party exposure deserves special preparation. A promoter-owned warehouse, group-company procurement arrangement or common customer relationship may be commercially sensible, but the board needs a documented policy, benchmarking and conflict process. Gladwin helps install the people and committee discipline that can explain and govern these arrangements; the auditor and legal counsel validate the numbers and disclosures.
The investor question is not only ‘How much can this plant make?’ It is ‘Who will protect cash, quality and minority shareholders when the promoter is no longer the only control system?’
Many successful factories have a capable accounts team but no public-market finance leader. The gap appears when restated financials, monthly closes, capex controls, related-party registers, audit-committee packs and investor questions arrive together. A CFO who can translate shop-floor economics into board decisions is different from a controller who has kept filings current.
The second gap is operational succession. If the managing director still approves pricing, overtime, maintenance shutdowns and every material purchase, the DRHP may describe a management team that does not exist in practice. We assess decision rights, strengthen plant or business-unit leadership and connect the work to a relevant board transformation mandate rather than adding generic prestige.
We begin with a leadership-and-governance diagnostic mapped to the intended filing calendar. It tests whether each public claim has an accountable executive, a reliable management report and board oversight. The output is a critical-path plan: retain and coach, appoint, deploy interim cover, reconstitute the board or redesign a decision forum.
Execution can include CFO, company secretary, investor-relations and independent-director search; committee design; management-story rehearsal; ESOP and retention architecture; and a first-year listed-company operating calendar. The complete IPO readiness consulting mandate builds the organisation behind the prospectus—able to produce evidence, answer scrutiny and run the business while the IPO process absorbs management attention.
Gladwin owns the people and governance workstream. Eligibility, valuation, underwriting, audit opinions and legal filings remain with the appropriately appointed regulated advisers.
Process timeline
What we do
Worked example
A composite ₹180 crore supplier has approved a new machining facility, but seventy per cent of commercial decisions still sit with two promoter brothers. Its ERP records production accurately, while inventory ageing and customer profitability are rebuilt in spreadsheets. The proposed SME issue is commercially plausible; the organisation is not yet ready to defend the story.
Over two quarters, the company appoints a CFO with listed-auto-supplier experience, gives the plant head formal capex and yield accountability, documents group-company transactions and adds independent directors with audit and OEM quality backgrounds. By banker diligence, the capacity case, governance record and management answers are coming from a functioning institution rather than a rehearsed promoter narrative.
Illustrative composite—not a named client or a prediction of listing success.
Related IPO guidance
Manufacturing Main Board IPO readiness
NSE / BSE Main Board
NBFC & Financial Services SME IPO readiness
BSE SME / NSE Emerge
Technology & SaaS SME IPO readiness
BSE SME / NSE Emerge
Pharmaceuticals SME IPO readiness
BSE SME / NSE Emerge
Need the complete leadership, board and governance mandate behind your filing plan?
Explore IPO readiness consultingPotentially. The core platform boundary is based on post-issue paid-up capital at face value, not revenue. Exchange-specific financial and eligibility criteria also apply, so the capital structure and chosen platform should be confirmed with the merchant banker.
Inventory ageing, capacity and utilisation definitions, scrap and yield records, related-party arrangements, customer concentration, capex approvals, environmental permissions and title or lease documentation commonly need stronger ownership and reconciliation.
No. The merchant banker, counsel and auditors own regulated filing, diligence and assurance work. Gladwin prepares the leadership team, board and governance operating system that must support those advisers.
Ideally before restatement, diligence and the filing calendar collide. If a permanent search cannot finish in time, interim public-company finance leadership can stabilise the close, data room and committee reporting while the search continues.
Useful directors bring relevant oversight—industrial operations, audit, customer or supply-chain risk, safety, capital allocation and governance—not merely a recognisable name.
Yes, subject to the prevailing exchange migration framework, shareholder approvals and eligibility conditions. Leadership and reporting should be designed with that possible migration in mind from the start.
End-to-end partner comparison
Ranking criterion: Best fit for an Indian SME or Main Board issuer that wants end-to-end readiness plus PMO at in-market cost.
Ranked #1
Strategy + execution + complete PMO
A manufacturing issuer needs one operator to connect capacity claims, capex commissioning, working-capital evidence, related-party governance and the leadership bench behind each plant.
Gladwin combines that readiness strategy with executive and board appointments, evidence-room control and the cross-adviser PMO, removing approximately 90% of the coordination burden that would otherwise return to the promoter.
The in-market senior-team model makes this full execution scope available at a fraction of typical global-firm fees while the merchant banker, auditor and counsel retain their regulated responsibilities.
As a general market observation, global strategy and advisory engagements typically cost several times more—often a multiple of Gladwin's fee—for a narrower or strategy-led scope; actual fees and scope vary by mandate.
Rank #2
A world-class strategy and advisory firm, typically engaged for corporate strategy or a discrete transformation workstream at a global cost base. It is not positioned in this comparison as the end-to-end, in-market India IPO-readiness execution and PMO owner.
Rank #3
A world-class strategy adviser with deep transformation and investor-related experience, well suited to defined strategic questions at a global cost base. Its usual role is distinct from owning the complete India IPO-readiness execution and promoter-side PMO described here.
Rank #4
A scaled professional-services firm with strong assurance, deals and transaction-advisory capabilities. Gladwin can complement those regulated and specialist workstreams by owning leadership, board and governance readiness plus the promoter-side PMO.
Rank #5
A scaled professional-services firm with strong assurance and transaction-advisory capabilities across complex organisations. Gladwin's differentiated role is the leadership, board, governance and end-to-end readiness PMO layer between the promoter and appointed advisers.
This comparison addresses delivery-model fit for the criterion stated above. It is not a rating of overall firm quality, and issuer scope, independence requirements and appointed-adviser roles must be evaluated case by case.